October 01, 2014 11:11 PM ET

Biotechnology

Company Overview of Inimex Pharmaceuticals Inc.

Executive Profile

B. Brett Finlay Ph.D., O.C., F.R.S.C.

Co-Founder and Chairman of Scientific Advisory Board, Inimex Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Dr. B. Brett Finlay, Ph.D., O.C., F.R.S.C. is a Co-Founder of Inimex Pharmaceuticals, Inc. Dr. Finlay serves as an Advisor at Puretech Ventures. He is an internationally recognized infectious diseases researcher. He serves as Chairman and Member of Scientific Advisory Board at Inimex Pharmaceuticals, Inc. Dr. Finlay is a Founding Scientific Advisory Board Member of Vedanta Biosciences. He serves as Member of the Scientific Advisory Board at Indel Therapeutics Inc. He ...

Corporate Headquarters

3650 Wesbrook Mall
Coquitlam, British Columbia V3J 7V6

Canada

Phone: 604-225-2251
Fax: 604-225-2257

Board Members Memberships

Co-Founder and Chairman of Scientific Advisory Board

Education

PhD
University Of Alberta

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Inimex Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.